38 related articles for article (PubMed ID: 30942098)
1. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
2. High-grade serous papillary ovarian carcinoma combined with nonkeratinizing squamous cell carcinoma of the cervix: a case report.
Wu M; Zhang W; He L; Zhu Y; Jiang X; Zhang L; Yuan X; Li T
Front Oncol; 2024; 14():1298109. PubMed ID: 38515573
[TBL] [Abstract][Full Text] [Related]
3. [Multiple primary malignancies combined with SWI/SNF complex-deficient gastric cancer: a case report and literature review].
Lü C; Wu X; Xia Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):495-498. PubMed ID: 37087597
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma.
Feng H; Cao S; Ouyang Q; Li H; Li X; Chen K; Zhang X; Huang Y; Zhang X; Ma X
Transl Androl Urol; 2023 Feb; 12(2):308-319. PubMed ID: 36915884
[TBL] [Abstract][Full Text] [Related]
5. Genetic, Surgical and Oncological Approach to Breast Cancer, with
Subaşıoğlu A; Güç ZG; Gür EÖ; Tekindal MA; Atahan MK
Eur J Breast Health; 2023 Jan; 19(1):55-69. PubMed ID: 36605468
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and prognosis of multiple primary malignant neoplasms complicated with renal cell carcinoma].
Qiu M; Lian YY; Lu M; Wang BS; Tian XJ; Lu J; Liu C; Zhang SD; Jiang M; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):680-685. PubMed ID: 35950392
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of breast cancer susceptibility gene 1 expression in resected non-small cell lung cancer: A meta-analysis.
Gao Y; Luo XD; Yang XL; Tu D
World J Clin Cases; 2021 Oct; 9(30):9090-9100. PubMed ID: 34786391
[TBL] [Abstract][Full Text] [Related]
8. Heterochronic triple primary malignancies with Epstein-Barr virus infection and tumor protein 53 gene mutation: A case report and review of literature.
Peng WX; Liu X; Wang QF; Zhou XY; Luo ZG; Hu XC
World J Clin Cases; 2021 Feb; 9(5):1184-1195. PubMed ID: 33644183
[TBL] [Abstract][Full Text] [Related]
9. A Multiple Primary Malignancy Patient With FANCA Gene Mutation: A Case Report and Literature Review.
Xia Q; Zhao LY; Yan YD; Liao Y; Di YS; Xiao XY
Front Oncol; 2020; 10():1199. PubMed ID: 32850347
[No Abstract] [Full Text] [Related]
10. The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers.
Friedenson B
BMC Cancer; 2007 Aug; 7():152. PubMed ID: 17683622
[TBL] [Abstract][Full Text] [Related]
11. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
Wang W
Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
[TBL] [Abstract][Full Text] [Related]
12. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Wang L; Wang H; Wang T; Liu J; Chen W; Wang Y; Chen C; Zhu H; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1101-1112. PubMed ID: 30942098
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.
Litim N; Labrie Y; Desjardins S; Ouellette G; Plourde K; Belleau P; ; Durocher F
Mol Oncol; 2013 Feb; 7(1):85-100. PubMed ID: 23021409
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
